Navigation Links
SciQuest Announces Newest Life Sciences Customer; BioMarin Pharmaceutical Drives Spending Effectiveness with Automated, Intuitive Procurement
Date:6/25/2008

SciQuest Solution Enables Enhanced Productivity and Decreased Expenses

CARY, N.C., June 25 /PRNewswire/ -- SciQuest, Inc., the global leader in helping academic, healthcare and research-centric organizations realize the potential of strategic procurement, today announced that BioMarin Pharmaceutical Inc., a leading biopharmaceutical research and development firm, has chosen the SciQuest eprocurement platform to streamline and enhance procurement functions for its operations in Novato, Calif.

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, delivering first-to-market therapeutic treatments to patients with rare genetic disorders. The company's portfolio comprises three FDA-approved products and multiple clinical and preclinical product candidates.

"SciQuest's solution is extremely intuitive and allows our employees to manage and acquire their own materials and supplies quickly and easily," said Isaac Young, director of Supply Chain Operations for BioMarin. "This allows our employees to be more efficient and allows them to focus their efforts on our core business activities."

BioMarin uses SciQuest's SelectSite(TM) Express platform to maximize procurement cost savings and streamline the procurement process. SciQuest provides clear visibility into the progress of BioMarin's purchases through each step of the approval process. SciQuest then seamlessly integrates with BioMarin's ERP infrastructure for accounting and order tracking purposes.

For BioMarin, SciQuest's clear and demonstrated ROI, coupled with its industry-leading easy-to-use interface made it the solution of choice for its employees to handle their own procurement needs.

"SciQuest enables life sciences organizations to perform more effectively by ensuring that staff can quickly procure essential materials so that they can remain focused on developing new treatments," said Stephen Wiehe, president and CEO of SciQuest. "By allowing companies to attain superior control and insight into their procurement spending, SciQuest provides tremendous cost savings which can be further utilized to advance their missions of research and discovery."

About SciQuest

SciQuest is the global leader in helping academic, healthcare and research-centric organizations realize the potential of strategic procurement. The company's specialized knowledge, on-demand software, and service-first approach empower more than 100 of the best-known academic, pharmaceutical, biotechnology, research hospitals, and ambulatory surgical organizations to manage spend, drive ROI, and advance their critical missions.

SciQuest's strategic procurement solutions are strengthened by a deep understanding of the higher education, clinical and research environments combined with a broad supplier network for everything from lab equipment to office supplies to services. The company's intuitive, online shopping experience and diverse supplier offerings are proven to increase user and contract adoption. Through software-as-a-service (SaaS) deployment, organizations can quickly implement the right eprocurement solution, whether it's a robust shopping platform for existing eprocurement tools or to fully enable all aspects of purchasing from sourcing to settlement.

For more information about SciQuest, please visit http://www.sciquest.com or call 877-710-0413 in the U.S. or +44 1794 341182 in Europe.

SciQuest is a registered trademark of SciQuest, Inc. Other trademarks contained herein remain the property of their respective owners.

SciQuest media contact:

Ken Phillips

Davies Murphy Group

781-418-2437

kphillips@daviesmurphy.com


'/>"/>
SOURCE SciQuest, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
2. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
3. SciQuest Continues to Surpass Milestones for Customer Wins, Growth and Market Share; Remains Clear Eprocurement Leader for Academic and Research-Centric Organizations
4. Array BioPharma Selects SciQuest to Automate Procurement and Enable Agile Drug Development
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
7. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
8. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
9. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
10. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
Breaking Biology News(10 mins):